Heart failure therapy more effective in women
Women derive twice the benefit from a device to treat heart failure as men, U.S. researchers said on Monday, underscoring the different ways in which men and women experience heart disease. Women treated with a combination pacemaker and defibrillator device had a 70% reduction in heart failure compared with a 35% decline in men, they said. "Our finding was unexpected, but extremely important because this is the only heart treatment that is clearly better in women than men," Dr. Arthur Moss, MD, of the University of Rochester Medical Center, whose study appears in the Journal of the American College of Cardiology, said in a statement. The findings come from a large Boston Scientific study of cardiac resynchronization therapy known as MADIT-CRT, in which a pacemaker is used to restore normal coordinated heart beats in people whose damaged hearts are less efficient at pumping blood.
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- CA Powers Up $80M HIE to 'Create Value in the Data'
- TJC Warns Hospitals of Deadly Medical Tubing Mistakes
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- 3 Traits Personality Assessments Can't Reveal
- The secret committee behind our soaring healthcare costs